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ABSTRACT
Antibiotic prophylaxis and advances in technology have reduced operative site infections after
hysterectomy to a minimum. Pelvic infections are the most common infection type and respond
promptly to a variety of parenteral single-agent and combination antibiotic regimens. Oral antibiotic
regimens following parenteral therapy are unnecessary. Abdominal incision infections are less
common than pelvic infections, less common than seromas or hematomas, and usually do not
require antimicrobial therapy. Abscesses or infected hematomas require parenteral antimicrobial
therapy, and drainage of those located above the cuff will predictably shorten therapy time. With
early discharge from the hospital, many infections will not become evident until after the patient is
home. For that reason, it is important that the patient’s discharge instructions outline symptoms
and signs associated with these infections so she can present for care at the earliest possible time.
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he late 1940s and early 1950s brought signifi-
cant advances to the field of elective pelvic
surgery. Surgical skill refinement, adherence to
sterile technique, improved suture material, and
reduction in lower reproductive tract bacterial in-
oculum were important advances, but not as im-
portant as the introduction of antibiotics. Richards
reported in 1944 that the local application of sul-
fonamide at the time of hysterectomy did not alter
infection rates or cause adverse events. Turnerz
reported 6 years later that penicillin vaginal sup-
positories significantly reduced infectious morbid-
ity following vaginal hysterectomy. Antimicrobial
prophylaxis currently is used by most gynecologists
performing hysterectomy, irrespective of route. If
infection rates are low without prophylaxis, how-
ever, antimicrobial prophylaxis is not indicated.
Without prophylaxis, the reported incidence of
operative site infection after hysterectomy ranged
from 5 to 70%, but most reports were mid-range,
and higher after vaginal hysterectomy. It was dif-
ficult to identify uniform risk factors for postopera-
tive infection other than lower socioeconomic sta-
tus, immunocompromised host, and infection or
flora overgrowth. A good example of the last vari-
able is the recently reported3,4 association between
preoperative bacterial vaginosis and an increase in
the rate of operative site infection following hys-
terectomy.
Bacteria that have been reported in flora and
infection studies and that are potential pathogens
recovered from operative site infections after hys-
terectomy are presented in Table 1. Bacterial in-
oculum and virulence factors are complex, expen-
sive to elucidate, and difficult to evaluate in the
clinical setting. As difficult to identify are cell-
mediated and humoral immune system function in
each patient. It is ultimately the interaction be-
*Correspondence to: Dr. David L. Hemsell, Department of Obstetrics and Gynecology, University of Texas Southwestern
Medical Center at Dallas, 5323 Harry Hines Boulevard, G6.226, Dallas, TX 75235-9032.
Review Article
Received 2 December 1996
Accepted 14 January 1997INFECTIONAFTER HYSTERECTOMY HEMSELL
TABLE I. Potential pathogens recovered from
operative site infections
Aerobic bacteria Anaerobic bacteria
Gram-positive cocci
Enterococcus faecalis
Streptococcus agalactiae
Streptococcus sp.
Staphylococcus aureus
Staphylococcus epidermidis
Gram-negative bacilli
Acinetobacter sp.
Citrobacter sp.
Enterobacter sp.
Escherichia coli
Haemophilus influenzae
Klebsiella sp.
Proteus sp.
Pseudomonas sp.
Gram-positive cocci
Peptostreptococcus sp.
Gram-negative bacilli
Prevotella bivius
Prevotella sp.
Bacteroides fragilis group
B. caccae
B. distasonis
B. melaninogenicus
B. ovatus
B. thetaiotaomicron
B. uniformis
Fusobacterium sp.
Gram-positive bacilli
Clostridium sp.
Bifidobacterium sp.
Eubacterium spo
Lactobacillus sp.
Propionibacterium sp.
Gram-negative cocci
Veillonella parvula
tween these variables, with modifications by me-
chanical or antimicrobial applications, which results
in the development of a clinically important opera-
tive site infection.
Hysterectomy has been classified as a "clean
contaminated" procedure because of the lower re-
productive tract flora and its introduction into the
operative site at surgery. There is little risk of con-
tamination of pelvic tissues until vaginal transec-
tion. That the entire procedure is carried out in a
contaminated field would explain why reported in-
fection rates following vaginal hysterectomy were
higher than those after abdominal hysterectomy,
and why antimicrobial prophylaxis was more pre-
dictably effective in preventing operative site in-
fection in women undergoing vaginal hysterec-
tomy.
The following is one classification for the types
of infection that can develop following hysterec-
tomy. Temperature elevation alone is not the hall-
mark of operative site infection requiring antimi-
crobial therapy. Vagina/cuff ce//u/itis undoubtedly
happens after every hysterectomy, irrespective of
surgical approach. The vaginal surgical margin is
erythematous, edematous, and hyperemic early fol-
lowing surgery, and there are purulent vaginal se-
cretions. This occurs with or without prophylaxis,
and is not usually, but may be associated with tem-
perature elevation and/or symptoms. If unassoci-
ated with symptoms and signs of infection, it does
not require treatment and disappears spontane-
ously. This physiologic response to incision may or
may not contribute to recurring temperature eleva-
tion in an asymptomatic patient, febrile morbidity,
which usually occurs during the first 48 h after sur-
gery. If symptoms develop, they are primarily cen-
tral, lower abdominal and pelvic discomfort, and
there is tenderness at the vaginal surgical margin
on bimanual examination without evidence of para-
metrial involvement. This may not be clinically
evident until after the patient is discharged from
the hospital.
Pelvic cellulitis, or lateral extension of cuff cellu-
litis, is the result of the inability of physician and
host to control the inflammatory response to the
vaginal surgical margin. Inflammation spreads lat-
erally to the parametrial region(s), and is associated
with lower abdominal, pelvic, back, and/or leg pain
and recurring temperature elevation, usually
>38C, which begins 48-72 h after surgery. At ex-
amination, there is lower abdominal tenderness,
which is usually more pronounced on one side. No
distinct masses are palpable at bimanual examina-
tion, although pelvic tissue tenderness is obvious
and corresponds to tender area(s) discovered at ab-
dominal examination.
If a tender mass is palpable in the operative site
of a woman with posthysterectomy pelvic infec-
tion, there arc several possibilities. The patient
may have a phlegmon, an area of intense cellulitis
and microabscesses. This tender, indurated area is
usually not diagnosed by sonography, but may be
identified by a pelvic computerized tomographic
(CT) scan, or magnetic resonance imaging. A pelvic
abscess also may complicate cellulitis. The most fre-
quent location for this more fluctuant tender mass
is just above the vaginal surgical margin; it is fre-
quently referred to as a cuff abscess. Vaginal probe
sonography is more sensitive than transabdominal
sonography for identifying such an abscess. An ab-
scess may also develop laterally in the extraperito-
heal space or in retained adnexa. If the patient has
an infected hematoma or abscess that is above the
vaginal surgical margin, draining that site by open-
ing the vaginal cuff will facilitate cure. This can
usually be done in a treatment room and does not
require another operative procedure. If abscesses
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are in the lateral pelvic tissues and inaccessible to
drainage from the cuff, percutaneous CT-guided
drainage may be necessary, but usually is not.
There rarely may be a requirement for laparotomy.
Rupture of an abscess in(to) the peritoneal cavity is
an event that requires immediate surgical therapy.
Many abdominal incision margins normally may
have a minimal amount of erythema while healing.
If the patient develops wound pain with advancing
erythema, fever, and tenderness, asound infection is
present. These typically develop 4 or 5 days after
surgery. Purulent exudate is usually found in vary-
ing volumes; it is also possible to have a positive
wound culture in the absence of purulent material
in an infected wound. Given time, purulent secre-
tions would be present. Seromas and hematomas
are not included in the infection category.
The patient may develop an operative site he-
matoma which is asymptomatic, but which serves
as an excellent growth medium for inoculated flora.
This may become an infected hematoma, and can be
located either centrally or laterally in the extraperi-
toneal spaces or in an abdominal incision. A hema-
toma is not usually associated with symptoms ini-
tially, and is neither palpable nor tender. The only
indication of its presence is an unexplained drop in
hemoglobin. Even if temperature elevation devel-
ops, patients are usually asymptomatic and the he-
matoma is not palpable in the pelvis at bimanual
examination, but vaginal probe sonography is an
effective means for detection.
Temperature elevation is the first sign of in-
fected hematoma, and does not occur until the 4th
postoperative day or later, now a time when pa-
tients are at home. Without treatment, and after
several days of fever, pain develops and the in-
fected hematoma is detectable at bimanual exami-
nation as a tender mass. It is important therefore to
diagnose a hematoma before the patient is dis-
charged. Parenteral antibiotic therapy is indicated
for an infected hematoma. Studies have not been
performed to determine whether oral antibiotic
would prevent clinical infection in an uninfected
hematoma. When located in an abdominal incision,
a hematoma is more clinically obvious and acces-
sible and is therefore diagnosed and treated (evacu-
ation) before infection develops.
Wound infection definitions were recently re-
viewed by the Centers for Disease Control and
Prevention (CDC)s and constitute another and
TABLE 2. Specific organ/space SSI
Sinusitis
Disc space
Vaginal cuff
Ear, mastoid
Endometritis
Endocarditis
Mediastinitis
Osteomyelitis
Joint or bursa
Gastrointestinal
tract
Meningitis or
ventriculitis
Myocarditis or
pericarditis
Breast abscess or mastitis
Arterial or venous infection
Eye, other than conjunctivitis
Spinal abscess without meningitis
Intracranial, brain abscess, or dura
Upper respiratory tract, pharyngitis
Other infections of the urinary tract
Oral cavity (mouth, tongue, or gums)
Other male or female reproductive
tract
Intra-abdominal, not specified
elsewhere
Other infections of the lower
respiratory tract
more general set of definitions. In their classifica-
tion, surgical site infections (SSI) are divided into
1) organ or space infection and 2) incisional infec-
tions.
Organ or space infections are defined as those that
develop in surgical sites other than the abdominal
incision that was opened during the operative pro-
cedure. An example would be pelvic infection after
hysterectomy. Table 2 lists the specific organ/space
surgical infection sites included in their definitions.
These infections must occur within 30 days of the
hysterectomy and must be accompanied by at least
one of the following: 1) purulent drainage from a
drain placed through a stab wound into the organ/
space; 2) organisms isolated from an aseptically ob-
tained culture of fluid or tissue in the organ/space;
3) an abscess or other evidence of infection involv-
ing the organ/space identified during reoperation or
by radiologic or histopathologic examination; or 4)
diagnosis of a SSI by a surgeon or, attending phy-
sician.
Because of the difficulty in the ability to asep-
tically obtain a culture from a pelvic infection site,
most infections are diagnosed clinically based on
patient symptoms, vital signs, and physical findings
at examination. Radiologic examination may be
useful in diagnosing an infected hematoma or an
abscess, however. Urine culture, complete blood
count (CBC) with differential count, blood cul-
tures, and chest X-ray are seldom necessary, but
hemoglobin should be monitored and an unex-
plained decrease should be investigated.
It must be remembered that a patient may also
develop non-surgical site infections after elective
pelvic surgery. For that reason, a complete exami-
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nation designed to detect an infection in any loca-
tion must be performed when evaluating the pa-
tient for operative site infection after hysterec-
tomy.
Incisional surgical site infections are subdivided in
the CDC definitions into superficial and deep in-
fections. Superficial infection must occur within 30
days and involve only the skin or skin and subcu-
taneous tissues. Either organisms isolated from an
aseptically obtained culture, or purulent drainage
must be present in the incision. One of these also
must be accompanied by at least one of the follow-
ing symptoms or signs: 1) redness or heat; 2) local-
ized swelling; 3) pain or tenderness; 4) deliberate
opening of incision by a surgeon (unless culture
negative); or 5) diagnosis by the surgeon or attend-
ing physician. These definitions do not include
stitch abscesses.
Deep incisiona/ surgical site infections must occur
within 30 days after hysterectomy. The diagnosis is
confirmed by at least one of the following: 1) pu-
rulent drainage from a deep incision, but not the
organ or space component of the surgical site; or 2)
a deep incision that is deliberately opened by a
surgeon when the patient has at least one of the
following signs or symptoms: 1) temperature
>38C; 2) an abscess or other evidence of infection
found at reoperation, by radiologic examination, or
at rcoperation by histopathologic diagnosis; or 3) if
the diagnosis is made by the surgeon or attending
physician. This diagnosis can also be made if a
deep incision dehisces spontaneously.
When symptomatic cuff cellulitis develops, the
non-penicillin allergic patient often can be treated
with an oral broad spectrum regimen such as
amoxicillin with sodium clavulanate (Augmcntin (R)
250-500 nag every 8 h. Clindamycin 450 mg orally
every 6 h is an alternative for the penicillin allergic
patient. For most women with pelvic infections
other than cuff cellulitis, parcnteral antibiotic
therapy is necessary, and women usually promptly
respond to parenteral antimicrobial therapy. Paren-
teral antibiotics should not be administered to
women given the diagnosis of presumed pelvic in-
fection without a pelvic examination.
Table 3 lists alphabetically several tested and
reported regimens that have been effective in the
treatment of women who develop operative site
pelvic infections after hysterectomy. Parenteral
TABLE 3. Tested and reported regimens that have
been effective in the treatment of women with
operative site infections after hysterectomy
Ampicillin/sulbactarn (Unasyn(R)) 3 g q 6 h
Cefotaxime (Claforan (R)) g q 8 h
Cefotetan (Cefotan(R)) 2 g q 12 h
Cefoxitin (Mefoxin (R)) 2 g q 6 h
Imipenem/cilastatin (Primaxin (R)) 500 mg q 8 h
Meropenem (Merem (R)) 500 mg q 8 h
Piperacillin (Piperacil (R)) 4 g q 6 h
Piperacillin and tazobactam (Zosyn (R)) 3.375 g q 6 h
therapy is continued until the patient has been afe-
brile 24-36 h. Oral antibiotic therapy is unneces-
sary after successful parenteral therapy.
6
The most important consideration in antibiotic
selection is predictable efficacy. Infections are
polymicrobial, and a broad spectrum of antibacte-
rial activity is necessary. The regimens listed in
Table 3 have comparable clinical efficacy in re-
ported trials. If regimens are comparable in effi-
cacy, then safety profile considerations are impor-
tant. If efficacy and safety profiles are similar, then
cost considerations become important. Without
doubt, combination antimicrobial therapy is also ef-
fective in the treatment of women with operative
site infection following hysterectomy. No compara-
tive trials have shown combination therapy to be
significantly more effective than single-agent
therapy, however, and multiple antibiotic regimens
are usually more expensive and always more labor
intensive for nurses. Clindamycin resistance is in-
creasingly reported, and we have observed an in-
creasing percentage of operative site infections that
were not cured until metronidazole was substituted
for clindamycin.
Patients that have a true type I hypersensitivity
reaction to penicillin antibiotics should not be ad-
ministered penicillins, cephalosporins, pcnems,
etc. Women who do not have a type I hypersensi-
tivity reaction to penicillin but develop a rash, etc.,
can be administered a cephalosporin. If a patient
has a type hypersensitivity reaction to penicillin,
then therapy should be combination and will con-
tain an anti-anaerobic antibiotic such as clindarny-
cin, 900 nag every 8 h or metronidazole at a loading
dose of 15 mg/kg, and then a maintenance dose of
7.5 mg/kg every 6 h. Either should bc combined
with an aminoglycoside, an antibiotic family effcc-
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tive against the gram-negative aerobic bacteria.
Gentamicin appears to be as effective as .other
aminoglycosides in the treatment of women with
posthysterectomy pelvic infection, and is the least
expensive.
Although gentamicin was historically adminis-
tered parenterally every 8 h, recent data indicate
that either 5 or 7 mg/kg once daily is as effective,
less expensive, and even less toxic than gentamicin
administered 3 times daily7-9 to patients with nor-
mal renal function. Peak and trough testing is un-
necessary with once daily dosing. If there is no
penicillin allergy, ampicillin 2 g every 6 h to cover
gram-positive aerobic bacteria should be added to
the metronidazole/gentamicin regimen, but may
not be necessary for women treated with clindamy-
cin and gentamicin. Vancomycin at a dose of 500
mg every 6 h should be given to women.with a type
hypersensitivity reaction to penicillin in place of
ampicillin. Newer quinolone antibiotics currently
undergoing phase III clinical trials have an excep-
tionally broad spectrum of activity, and will be
available in parenteral and oral preparations.
During treatment for infection, the patient
should be monitored at least twice daily to insure
success and to detect any adverse reaction which
might develop. Almost all superficial incisional in-
fections respond to opening and draining the area
with local wound care 3 times daily consisting of
irrigation and debriding with solutions such as hy-
drogen peroxide or acetic acid followed by normal
saline. Fine mesh gauze applied directly to the in-
cisional margins and medial packing with 4 x 4s, or
other sterile packing speeds granulation tissue de-
velopment. Antibiotic therapy is not usually neces-
sary. These wounds may be closed or allowed to
heal by secondary intention.
Antibiotic treatment failures are uncommon.
They may result from 1) development of resistant
species; 2) superinfection by different species in
the infection site; 3) lack of coverage for the patho-
gen by the empiric regimen; or 4) volume of infec-
tion. Adding to or changing the empiric antibiotic
regimen to expand predictable coverage will be
successful. In patients with an infected hematoma
or abscess, draining will usually facilitate cure. The
patient also may have a non-operative site infec-
tion, and drug fever must be remembered.
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